Tirzepatide access
Wellmedr vs altRx: Which One Offers Tirzepatide? (2026)
Wellmedr or altRx? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.4 and 8.7 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Put Wellmedr and altRx side by side and the marketing reads almost identically. The programs underneath do not.
Molecule availability is the fork here: altRx covers both semaglutide and tirzepatide, while Wellmedr publishes semaglutide alone. That matters most to anyone who may want to switch rather than simply escalate.
Below, the two programs are set against the things that change the bill — the advertised rate, the rate after the promotion expires, the medication class and the inclusions. Where a figure is not published, that is stated rather than estimated.
The short answer
- Easier to price in advance
- Wellmedr — Semaglutide from $89/mo on the 1-year plan. The other side quotes after intake, so a like-for-like total is not available before you apply.
- Most predictable bill
- Wellmedr — Price locked for the life of the plan, so titration does not change what you are charged.
- Tirzepatide access
- altRx — Tirzepatide at $149/mo; the other side publishes semaglutide only.
- Easiest to pay for
- altRx — Affirm, Klarna and Afterpay.
The short version: Wellmedr vs altRx
This is the whole comparison in one screen. The sections underneath explain which of these rows should decide it.
| Wellmedr | altRx | |
|---|---|---|
| Advertised price | Semaglutide from $89/mo on the 1-year plan | Semaglutide $89/mo, tirzepatide $149/mo |
| Rate after promotions | $89/mo | $89/mo |
| Pricing structure | Price locked for the life of the plan | Flat rate at every dose |
| Medication | Compounded semaglutide | Compounded semaglutide and compounded tirzepatide |
| Tirzepatide | Not published | $149/mo |
| Price transparency | Partly published | Published upfront |
| Support model | No coaching program stated | Clinician messaging included |
| Shipping | Free overnight shipping | Free, discreet 2-day delivery |
| Payment options | Card only, no financing published | Affirm, Klarna and Afterpay |
| Patient reviews | 4,925 | 14,820 |
| eRxDoctor score | 9.4/10 | 8.7/10 |
What you will have spent by month twelve
The cheapest first month and the cheapest year are frequently different providers. The totals below are the honest version, built from the rates each provider publishes.
| Wellmedr | altRx | |
|---|---|---|
| First month | $89 | $89 |
| Months 2 onward | $89/mo | $89/mo |
| 6-month total | $534 | $534 |
| 12-month total | $1,068 | $1,068 |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for : . Treat any comparison that quotes one as an estimate someone else has made for you.
Semaglutide, tirzepatide, and having somewhere to go next
Semaglutide is a GLP-1 receptor agonist. Tirzepatide adds GIP activity, and in head-to-head trial data it has produced larger average weight reductions. That does not make it the right first choice for everyone — it is typically more expensive and the side-effect profile is its own conversation — but it is the usual next step when semaglutide underdelivers.
altRx publishes both, with tirzepatide at $149/mo. Wellmedr publishes compounded semaglutide, so switching molecules would mean switching provider, repeating an intake and losing whatever pricing you had locked in.
If you are confident semaglutide is where you will stay, this difference costs you nothing. If you are not, it is worth more than a small monthly saving.
A closer look at Wellmedr
Wellmedr positions itself on locked-in pricing with no dose-based increases at one of the lowest published rates. GLP-1 Plans Starting at Just $89/Month
You start with same-day review; medication arrives via free overnight shipping. The price behaves as price locked for the life of the plan.
On the clinical side, same-day clinician review, prescribing compounded semaglutide.
Wellmedr pros
- Lifetime locked-in pricing
- No dose-based price increases
Wellmedr cons
The reservation worth holding, particularly next to altRx: the $89 rate is tied to a one-year commitment and the platform publishes little else.
Inside the altRx program
altRx is the most affordable GLP-1 program, limited offer: semaglutide $89/month and tirzepatide $149/month. 100% online medical visits, no membership, insurance or hidden fees, free and discreet 2-day delivery. Against Wellmedr, that puts it in the position of the more expensive option.
The process is 100% online medical visits, then free, discreet 2-day delivery. On money, expect flat rate at every dose — published upfront.
Behind the prescription sits responsive care team for ongoing clinician-guided support. Available medication: compounded semaglutide and compounded tirzepatide.
altRx pros
- Free and discreet 2-day delivery
- No commitment, cancel anytime
- Complete treatment kit: vials, syringes, prep pads, and step-by-step guidance
- Responsive care team for ongoing clinician-guided support
altRx cons
- Compounded medication, not FDA-approved branded product
- Not available in all U.S. states
Read next to Wellmedr, the weak point: the rate is a limited offer and the platform does not operate in every state.
Who should choose Wellmedr, and who should choose altRx
Choose Wellmedr if:
- the level of clinical contact suits you: same-day clinician review
- you want to start on their timeline: same-day review
- you want the price you sign up at to survive titration
- you would get real value from locked-in pricing with no dose-based increases at one of the lowest published rates
Choose altRx if:
- delivery works the way you want it to: free, discreet 2-day delivery
- you want to start on their timeline: 100% online medical visits
- the level of clinical contact suits you: responsive care team for ongoing clinician-guided support
- the feature you would actually use: the cheapest published tirzepatide rate on this list at $149, with the injection kit included
What each one gives up
On price. Only Wellmedr publishes a rate you can plan against (Semaglutide from $89/mo on the 1-year plan). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On clinical contact. Wellmedr provides same-day clinician review. altRx provides responsive care team for ongoing clinician-guided support. Both are asynchronous-first services and neither replaces a physician who can examine you.
On medication. Wellmedr covers compounded semaglutide; altRx covers compounded semaglutide and compounded tirzepatide. Only altRx publishes a tirzepatide route, which matters if semaglutide underdelivers.
On access. Wellmedr advertises same-day review and free overnight shipping; altRx advertises 100% online medical visits and free, discreet 2-day delivery. Coverage differs too — not published against not available in every state — which decides the question before price does if you are in a restricted state.
The clinical evidence, separated from the marketing
Before either program's marketing claims, the underlying evidence — which belongs to the medication, not the platform.
In SURMOUNT-1, tirzepatide reached a mean body-weight reduction of about 21% at the 15 mg dose over 72 weeks, per NEJM, SURMOUNT-1.
Weight regain after withdrawal is the documented pattern: the STEP 1 extension recorded participants returning to close to their starting weight a year after stopping, per Diabetes, Obesity and Metabolism.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
Wellmedr vs altRx: common questions
What happens when altRx's promotional price ends?
The rate moves to $89/mo, a 0% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Do Wellmedr or altRx take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Which has more patient reviews, Wellmedr or altRx?
altRx, with 14,820 against 4,925. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Can I switch from Wellmedr to altRx later?
You can, and people do — usually when an introductory price expires. Budget for a repeat intake and a short overlap in supply, and confirm what happens to any unused portion of a multi-month plan before you cancel it.
Is Wellmedr or altRx better for a first GLP-1 prescription?
First-timers usually get more from clinical access than from a lower rate, because the first two months are where most people stop. On that basis altRx has the stronger case; after month three, cost should take over.
Do Wellmedr and altRx prescribe the same medication?
Both dispense compounded GLP-1 preparations. Wellmedr lists compounded semaglutide and altRx lists compounded semaglutide and compounded tirzepatide, so the molecules overlap even where the formulary does not match exactly.
Does Wellmedr or altRx offer tirzepatide?
altRx does, at $149/mo. Wellmedr publishes compounded semaglutide only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. Wellmedr leads on locked-in pricing with no dose-based increases at one of the lowest published rates; altRx leads on the cheapest published tirzepatide rate on this list at $149, with the injection kit included.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
Neither choice is irreversible. Start with the program whose weaknesses you can tolerate, and reassess at month three when you know how you respond to the medication.
Keep comparing
- Wellmedr vs Start WillowBudget vs premium
- Wellmedr vs RefillsTirzepatide access
- altRx vs MeasuredHead to head
- altRx vs GalaBudget vs premium
- Measured vs Mochi HealthTirzepatide access
- Gala vs Start WillowTirzepatide access
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Wellmedr or altRx, and does not sell treatment. Read our ranking methodology.